Matching Items (7)
Filtering by

Clear all filters

Description

Eosinophilic esophagitis (EoE) is an allergic disease characterized by eosinophilic inflammation, tissue remodeling (e.g. fibrosis), and dysfunction of the esophagus. Symptoms include trouble swallowing (dysphagia), food getting stuck in the esophagus (impaction), regurgitation, abdominal pain, and GI distress/vomiting. Clinical limitations include: 1) Diagnosis and monitoring of EoE requires multiple invasive

Eosinophilic esophagitis (EoE) is an allergic disease characterized by eosinophilic inflammation, tissue remodeling (e.g. fibrosis), and dysfunction of the esophagus. Symptoms include trouble swallowing (dysphagia), food getting stuck in the esophagus (impaction), regurgitation, abdominal pain, and GI distress/vomiting. Clinical limitations include: 1) Diagnosis and monitoring of EoE requires multiple invasive upper endoscopic procedures to retrieve esophageal biopsies for histopathological assessment of eosinophilic infiltrate. 2) The manual quantification of tissue eosinophils is a laborious and subjective process. 3) The disease mechanisms of EoE are not well understood and treatment options are limited. Mouse models that recapitulate pathology seen in human EoE have been critical in advancing our understanding of EoE to help address these limitations. Recently, there have been efforts to develop pig models of EoE, as pig esophageal anatomy better resembles that of humans. We designed and optimized an immunohistochemistry (IHC) staining protocol targeting eosinophil peroxidase (EPX), an eosinophil-specific granule protein, to assess esophageal eosinophilia in a pig model of EoE. The optimized IHC protocol demonstrated successful positive staining of eosinophils in pig esophageal tissue samples and distinguished a pig model of EoE from controls. EPX staining is a useful tool for evaluating pig eosinophils by IHC. This novel IHC staining protocol provides the opportunity to further our current understanding of the histopathology, immunologic mechanisms, and potential treatment options for EoE.

ContributorsPutikova, Arina (Author) / Sellner, Erin (Thesis director) / Wright, Benjamin (Committee member) / Doyle, Alfred (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / College of Health Solutions (Contributor)
Created2023-05
131976-Thumbnail Image.png
Description
The purpose of this project was to characterize the mucin layer in patients with eosinophilic esophagitis (EoE). EoE is a chronic disease that is characterized by eosinophilic inflammation in the esophagus. The current diagnosis and standard of care for patients with EoE is less than ideal. Diagnosis is highly invasive

The purpose of this project was to characterize the mucin layer in patients with eosinophilic esophagitis (EoE). EoE is a chronic disease that is characterized by eosinophilic inflammation in the esophagus. The current diagnosis and standard of care for patients with EoE is less than ideal. Diagnosis is highly invasive as it requires histological confirmation of eosinophilic inflammation in the esophagus, the patient must undergo an upper endoscopy to obtain the tissue sample. The histology as determined by the pathologist is subjective not quantitative which causes significant error in diagnosis. The current treatment methods are dietary therapy or corticosteroids, which require significant cost and time. The pathology of EoE is largely unknown, though it is known to involve allergic inflammatory and type-2 cytokine-mediated responses. Past studies have determined the genetic expression of mucins to be varied in the esophagi of EoE patients using RNA sequencing techniques. The varied expression of mucins in the esophagi of EoE patients has not been validated at the protein level. This study sought to better define mucin protein expression, specifically that of MUC1, MUC4, and MUC7, in the esophagi of EoE patients (n=4) and control patients (n=3). This was accomplished using histological staining. The tissue samples were stained for eosinophil peroxidase (EPX) in order to visualize the eosinophils, which are a pathological marker of EoE. The results of this study showed a qualitative increase in the protein expression of MUC4 in patients with EoE, indicating that MUC4 may play a protective role in the body’s defense against EoE. MUC1 and MUC7 staining showed no pattern. This study defined the conditions necessary for precise staining of esophageal tissues with the MUC4 8G7 antibody. The orientation of the tissue samples on the slides and the small sample size created significant difficulty in analysis and inhibited quantitative analysis. Future studies with tissue orientation standardization and greater sample size are needed to confirm the findings of this study. If verified, the increase of MUC4 protein expression in patients with EoE has implications for EoE diagnostics and therapeutics.
ContributorsCall, Abigail (Author) / Plaisier, Christopher (Thesis director) / Jacobsen, Elizabeth (Committee member) / Chemical Engineering Program (Contributor) / Barrett, The Honors College (Contributor)
Created2020-05
Description
Recent studies in traumatic brain injury (TBI) have found a temporal window where therapeutics on the nanometer scale can cross the blood-brain barrier and enter the parenchyma. Developing protein-based therapeutics is attractive for a number of reasons, yet, the production pipeline for high yield and consistent bioactive recombinant proteins remains

Recent studies in traumatic brain injury (TBI) have found a temporal window where therapeutics on the nanometer scale can cross the blood-brain barrier and enter the parenchyma. Developing protein-based therapeutics is attractive for a number of reasons, yet, the production pipeline for high yield and consistent bioactive recombinant proteins remains a major obstacle. Previous studies for recombinant protein production has utilized gram-negative hosts such as Escherichia coli (E. coli) due to its well-established genetics and fast growth for recombinant protein production. However, using gram-negative hosts require lysis that calls for additional optimization and also introduces endotoxins and proteases that contribute to protein degradation. This project directly addressed this issue and evaluated the potential to use a gram-positive host such as Brevibacillus choshinensis (Brevi) which does not require lysis as the proteins are expressed directly into the supernatant. This host was utilized to produce variants of Stock 11 (S11) protein as a proof-of-concept towards this methodology. Variants of S11 were synthesized using different restriction enzymes which will alter the location of protein tags that may affect production or purification. Factors such as incubation time, incubation temperature, and media were optimized for each variant of S11 using a robust design of experiments. All variants of S11 were grown using optimized parameters prior to purification via affinity chromatography. Results showed the efficiency of using Brevi as a potential host for domain antibody production in the Stabenfeldt lab. Future aims will focus on troubleshooting the purification process to optimize the protein production pipeline.
ContributorsEmbrador, Glenna Bea Rebano (Author) / Stabenfeldt, Sarah (Thesis director) / Plaisier, Christopher (Committee member) / Harrington Bioengineering Program (Contributor, Contributor) / Barrett, The Honors College (Contributor)
Created2019-05
131006-Thumbnail Image.png
Description
Eosinophilic Esophagitis (EoE) is a chronic autoimmune disease that causes inflammation of the esophagus due to food allergy. In pediatric EoE, remission can be reduced by 95% through the use of hypoallergenic amino acid formulas (AAF), however its bitter taste gives it poor palatability, making nutrition difficult. This thesis highlights

Eosinophilic Esophagitis (EoE) is a chronic autoimmune disease that causes inflammation of the esophagus due to food allergy. In pediatric EoE, remission can be reduced by 95% through the use of hypoallergenic amino acid formulas (AAF), however its bitter taste gives it poor palatability, making nutrition difficult. This thesis highlights the problem of poor palatability of AAF's and explores the idea of prototyping a new flavor enhanced recipe to minimize bitterness for EoE patients and how to evaluate it through sensory evaluation practices. Along the way, I also discovered that quail egg homogenate has novel therapeutic potential to reduce EoE symptoms.
ContributorsBorah, Priya Anjali (Co-author) / Holmes, Katherine (Co-author) / Serrano, Osvin (Co-author) / Spackman, Christy (Thesis director) / Schroeder, Shauna (Committee member) / Harrington Bioengineering Program (Contributor) / Barrett, The Honors College (Contributor)
Created2020-12
130956-Thumbnail Image.png
Description

Eosinophilic Esophagitis, EoE, is a newer autoimmune chronic esophageal inflammatory illness that results from food allergen triggers (Lucendo, 2017). EoE has created a wide range of diagnostic challenges for physicians because of the similarities that it has compared to gastroesophageal reflux disease, GERD. Current research indicates that EoE predominately impacts

Eosinophilic Esophagitis, EoE, is a newer autoimmune chronic esophageal inflammatory illness that results from food allergen triggers (Lucendo, 2017). EoE has created a wide range of diagnostic challenges for physicians because of the similarities that it has compared to gastroesophageal reflux disease, GERD. Current research indicates that EoE predominately impacts males at higher rates compared to females, while White males are most affected by and at risk for developing EoE compared to people of other racial and ethnic backgrounds (Sperry, 2012). Despite these findings, there continues to be an absence of research on social factors and identities like gender, race, ethnicity, income, sexuality and more, that are neglected in understanding how these features interact with EoE. Thus, the purpose of this thesis was to provide more evidence on identity and social aspects in relation to EoE that remain ignored and explain why there might be difficulties in investigating these topics. Moreover, a survey was also developed in order to better understand the current EoE population between the ages of 18 to 26, in which the transition from pediatric to adult care occurs. Language has been shown to affect patient’s care and treatment regarding their health because of discriminations that patients have been subjected to in the past. Therefore, it is important to discuss the role played by language and political correctness, especially within surveys. This thesis will explore the depth of study that has been completed within neglected areas of research surrounding marginalized communities, while providing new insights and questions for future possible research regarding EoE. This will be accomplished by discussing the existing problems within each topic and draw conclusions as to why EoE research may have been hindered within these neglected subjects. This project will provide a literature review, survey development, and language strategies for conducting inclusive and diverse populations and research topics centered around EoE.

ContributorsSerrano, Osvin (Author) / Spackman, Christy (Thesis director) / Schroeder, Shauna (Committee member) / School of Art (Contributor) / School of Politics and Global Studies (Contributor) / School of Life Sciences (Contributor) / School of Human Evolution & Social Change (Contributor) / Barrett, The Honors College (Contributor)
Created2020-12
130976-Thumbnail Image.png
Description
With an ever-increasing diagnosis rate and no universal cure, eosinophilic esophagitis (EoE) lacks conclusive data regarding the onset of its autoimmune response and its preferred relation to assigned sex males. This thesis seeks to analyze the effects that assigned sex and determinants of health have on EoE diagnosis through previous

With an ever-increasing diagnosis rate and no universal cure, eosinophilic esophagitis (EoE) lacks conclusive data regarding the onset of its autoimmune response and its preferred relation to assigned sex males. This thesis seeks to analyze the effects that assigned sex and determinants of health have on EoE diagnosis through previous research and survey development. Upon constructing a Qualtrics survey to collect data patterns and trends of subjects diagnosed with this autoimmune disorder, COVID-19 created a halt in its distribution and data collection. This unexpected event led to the collection and compilation of pre-existing research to be implemented into this thesis as a substitute. The key results of this thesis revealed that in twenty research studies regarding sex differences in EoE, at least 70% of patients diagnosed with EoE were male (Liacouras, 2005). With inconclusive results as to why males are diagnosed at a higher rate, results have not confirmed if this percentage ratio is due to social or genetic factors. To conclude, males are predominately diagnosed with EoE in comparison to the female and intersex population, however, with no data currently available on the effects that EoE has on intersex humans, it cannot be determined what factors create this recurring pattern.
ContributorsHolmes, Katherine Elizabeth (Co-author) / Serrano, Osvin (Co-author) / Borah, Priyah (Co-author) / Spackman, Christy (Thesis director) / Schroeder, Shauna (Committee member) / School of Human Evolution & Social Change (Contributor) / School of Life Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2020-12
Description
Background: Eosinophilic esophagitis (EoE) is an increasingly prevalent allergic disease characterized by eosinophilic inflammation and symptoms of esophageal dysfunction. Diagnosis and monitoring require repeated, invasive endoscopic esophageal biopsies to assess levels of eosinophilic inflammation. Recently, the minimally invasive esophageal string test (EST) has been used collect protein in mucosal secretions

Background: Eosinophilic esophagitis (EoE) is an increasingly prevalent allergic disease characterized by eosinophilic inflammation and symptoms of esophageal dysfunction. Diagnosis and monitoring require repeated, invasive endoscopic esophageal biopsies to assess levels of eosinophilic inflammation. Recently, the minimally invasive esophageal string test (EST) has been used collect protein in mucosal secretions as a surrogate for tissue biopsies in monitoring disease activity. From the string, assessment of the eosinophil-associated proteins major basic protein-1 (MBP-1) and eotaxin-3 (Eot3) is used to assess disease activity; however, this requires measurement in a reference laboratory, for which the turnaround time for results exceeds the time required for histopathologic assessment of endoscopic biopsies. In addition, MBP-1 and Eot3 are not markers unique to eosinophils. These obstacles can be overcome by targeting eosinophil peroxidase (EPX), an eosinophil-specific protein, using a rapid point-of-care test. Currently, EPX is measured by a labor-intensive enzyme-linked immunosorbent assay (ELISA), but we sought to optimize a rapid point-of-care test to measure EPX in EST segments. Methods: We extracted protein from residual EST segments and measured EPX levels by ELISA and a lateral flow assay (LFA). Results: EPX levels measured by LFA strongly correlated with those quantified by ELISA (rs = 0.90 {95% CI: 0.8283, 0.9466}). The EPX LFA is comparable to ELISA for measuring EPX levels in ESTs. Conclusions: The EPX LFA can provide a way to rapidly test EPX levels in ESTs in clinical settings and may serve as a valuable tool to facilitate diagnosis and monitoring of EoE.
ContributorsDao, Adelyn (Author) / Lake, Douglas (Thesis director) / Borges, Chad (Committee member) / Wright, Benjamin (Committee member) / Barrett, The Honors College (Contributor) / School of Molecular Sciences (Contributor) / School of Life Sciences (Contributor)
Created2024-05